CClinicalTrials.gg
RecruitingNCT07822945Updated Sep 16, 2026

Healthcare Practitioners Knowledge on Diabetes Technology

An observational study in Diabetes Technology, Continuous Glucose Monitoring System and Continuous Insulin Infusion System, sponsored by Aristotle University Of Thessaloniki. Recruiting at 1 site in Greece. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Aristotle University Of Thessaloniki · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
112
Sex
All
01

Study summary

Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece

Read the detailed description

Data will be collected using a standardized questionnaire. This questionnaire is based on a review of the relevant literature on diabetes management and related technologies. The final instrument consists of 37 closed-ended items. It was organized into four main sections, covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. Demographics will be also collected along with diabetes knowledge questions and 2 sections (1 for insulin pumps and 1 for continuous glucose monitoring).

02

Conditions studied

  • Diabetes Technology
  • Continuous Glucose Monitoring System
  • Continuous Insulin Infusion System
  • Insulin Pump Therapy

Keywords

  • healthcare professional
  • diabetes technology
  • continuous glucose monitoring
  • insulin pump therapy
  • continuous insulin infusion system
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthcare professionals practicing at the University General Hospital of Thessaloniki "AHEPA"

Inclusion criteria

  • All qualified and registered HCP practicing at the University General Hospital of Thessaloniki "AHEPA" , who were involved in direct patient care.
  • Actively working during the data collection period.

Exclusion criteria

Exclusion Criteria:

  • Administrative staff and personnel not directly involved in patient care.
  • HCP who declined to participate.
  • Participants who did not complete the questionnaire in full.
04

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
112 participants (estimated)
Patient registry
No

Groups and cohorts

  • Observation group

    Healthcare professionals working in a tertiary university hospital

    Other: Questionnaire assessing knowledge on diabetes technology

Interventions

  • OtherQuestionnaire assessing knowledge on diabetes technology

    A standardized questionnaire developed specifically based on a review of the relevant literature on diabetes management and related technologies

05

What researchers measure

Primary outcomes

  1. Knowledge of Diabetes Mellitus aspects

    Questions on diabetes types, diagnostic criteria, risk factors for hypo- and hyperglycemia, symptom recognition, and glycemic targets.

    Time frame: Through study completion, an average of 1 year and 3 months

Secondary outcomes

  1. knowledge on insulin use

    The instrument was a questionnaire of 37 closed ended items organized in 4 sections covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. The questions for insulin use covered the knowledge of healthcare professionals on insulin regimens, dose calculation and administration, principles and benefits of insulin pump therapy, potential complications and appropriate actions in case of device malfunction.

    Time frame: Through study completion, an average of 1 year and 3 months

  2. Knowledge of healthcare professionals on continuous glucose monitoring systems

    Questions on system function, accuracy, indications for use, contribution to glycemic control, sensor placement and common issues during use.

    Time frame: Through study completion, an average of 1 year and 3 months

06

Study locations

1 of 1 sites recruiting
  • University General of Thessaloniki AHEPA
    Thessaloniki, 54636, Greece
    • Triantafyllos Didangelos, Professor of Internal Medicine · Contact · didang@auth.gr · +302310994776
    • Zisis Kontoninas, MD, PhD · Contact · drziko2401@gmail.com
    • Triantafyllos Didangelos, Professor of Internal Medicine · Principal investigator
    • Zisis Kontoninas, MD,PhD · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because of the General Data Protection Regulation and the regulations of the Ethics committee of the hospital

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07822945
Lead sponsor
Aristotle University Of Thessaloniki
Responsible party
Prof. Triantafyllos Didangelos (Professor of Internal Medicine and Diabetology, Aristotle University Of Thessaloniki) — Principal investigator
First posted
Sep 16, 2026
Start date
Jun 1, 2025
Primary completion
Sep 15, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Sep 16, 2026

Study contacts

Triantafyllos Didangelos, Professor of Internal Medicine
Contact
didang@auth.gr
+302310994776
Zisis Kontoninas, MD, PhD
Contact
drziko2401@gmail.com
Triantafyllos Didangelos
principal investigator · Aristotle University Of Thessaloniki
Zisis Kontoninas, MD, PhD
study director · Aristotle University Of Thessaloniki

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion